Amneal to Participate at the 2023 Wells Fargo Healthcare Conference
25 Agosto 2023 - 9:00AM
Business Wire
Amneal Pharmaceuticals, Inc. (NYSE: AMRX) (the “Company”) today
announced that Chirag Patel, Co-Chief Executive Officer and
President, and Tasos Konidaris, Chief Financial Officer, will
participate at the 2023 Wells Fargo Healthcare Conference on
September 7, 2023 in Boston. Mr. Patel will also be hosting a
fireside chat at 8:00 AM Eastern Time and a live webcast will be
accessible through the Investor Relations section of the Company's
website at https://investors.amneal.com. A replay of the webcast
will be posted shortly after the presentation and will be available
for 90 days following the event.
About Amneal Amneal Pharmaceuticals, Inc. (NYSE: AMRX),
headquartered in Bridgewater, NJ, is a fully integrated global
pharmaceuticals company. We make healthy possible through the
development, manufacturing, and distribution of a diverse portfolio
of approximately 270 pharmaceutical products, primarily within the
United States. In its Generics segment, the Company is expanding
across a broad range of complex product categories and therapeutic
areas, including injectables and biosimilars. In its Specialty
segment, Amneal has a growing portfolio of branded pharmaceuticals
focused primarily on central nervous system and endocrine
disorders, with a pipeline focused on unmet needs. Through its
AvKARE segment, the Company is a distributor of pharmaceuticals and
other products for the U.S. federal government, retail, and
institutional markets. For more information, please visit
www.amneal.com.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20230825020989/en/
Anthony DiMeo Head of Investor Relations
Anthony.DiMeo@amneal.com
Amneal Pharmaceuticals (NYSE:AMRX)
Gráfico Histórico do Ativo
De Mai 2024 até Jun 2024
Amneal Pharmaceuticals (NYSE:AMRX)
Gráfico Histórico do Ativo
De Jun 2023 até Jun 2024